Drug Profile
Research programme: AMPA modulators - Servier
Alternative Names: Compound 103Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Servier
- Class
- Mechanism of Action AMPA receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported CNS disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in CNS-disorders in France
- 19 Nov 2008 Preclinical trials in CNS disorders in France (unspecified route)